Denosumab-Postmenopausal Osteoporosis drug found safe in long-term trial supriya kashyap kashyap9 April 2017 10:31 AM ISTA new study provides reassuring information about the short-term and long-term safety of denosumab, a monoclonal antibody that is used to treat...
Bone loss after denosumab only partial protection with zoledronate Anjali Nimesh Nimesh4 Aug 2017 9:30 AM ISTDenosumab is a monoclonal antibody which acts as a potent anti-resorptive agent and is now widely used in the treatment of osteoporosis.However, when...
Denosumab more effective in glucocorticoid-induced osteoporosis Vinay Singh singh30 April 2018 7:05 PM ISTDenosumab found superior to risedronate, as measured by increased bone density in the lower spine in glucocorticoid-induced secondary osteoporosis,...
ESMO Guidelines on management of cancer pain Medha Baranwal Baranwal18 Aug 2018 7:03 PM ISTThe European Society for Medical Oncology (ESMO) has released clinical practice guidelines on the management of cancer pain in adult patients. The...
Denosumab superior to bisphosphonates for osteoporosis in TDT Vinay Singh singh1 Nov 2018 7:10 PM ISTWashington: Denosumab (DNM) may be another valuable option for the management of TDT-induced osteoporosis.A new study published in the journal Blood...
Denosumab superior to bisphosphonates in osteoporosis Vinay Singh singh16 Dec 2018 7:20 PM ISTA new study published in JCEM has reported that denosumab effectively increased bone mass in patients with low bone mineral density(BMD) or...
Pharmacologic treatment of osteoporosis- Endocrine Society Guidelines Dr. Kamal Kant Kohli Kohli28 March 2019 7:00 PM ISTThe Endocrine Society has released new guidelines on the pharmacologic treatment of osteoporosis in postmenopausal women. The guideline provides...
Pharmacologic treatment of osteoporosis in postmenopausal women: Endocrine Society guidelines Medha Baranwal Baranwal28 May 2019 7:00 PM ISTThe Endocrine Society has released guidelines on the pharmacologic treatment of osteoporosis in postmenopausal women.The guidelines are published in...
Bisphosphonates prevent rebound bone decay due to discontinuation of denosumab in Osteoporosis Medha Baranwal Baranwal3 July 2019 7:10 PM ISTRecent research demonstrates that prescribing a bisphosphonate after denosumab has been discontinued could prevent rebound of bone decay symptoms in...
